Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442286 · ClinicalTrials.gov registry record · NA
Rheos® Pivotal Trial
A NA study, sponsored by CVRx.
- Completed
- Registry status
- NA
- Development phase
- 591
- Enrollment target
NCT00442286: Completed NA study, sponsored by CVRx.
NCT00442286 is a NA study that has completed, run by CVRx. The registered enrollment target is 591 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00442286, a NA study, has completed, sponsored by CVRx.
- COMPLETED
- Registry status
- NA
- Development phase
- 591 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with hypertension that are resistant to treatment with at least three anti-hypertension agents, one of which is a diuretic.
Interventions
- DEVICE Rheos® Baroreflex Hypertension System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 591 participants |
| Start Date | 2006-10 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00442286
The ClinicalTrials.gov registry entry for NCT00442286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 591 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CVRx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rheos® Baroreflex Hypertension System is the first listed.
NCT00442286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00442286 about?
NCT00442286 is a clinical study titled "Rheos® Pivotal Trial". The purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with hypertension that are resistant to treatment with at least three anti-hypertension agents, one of which is a diuretic.
What is the current status of trial NCT00442286?
This trial is currently completed. It is a NA study. The enrollment target is 591 participants. The study started on 2006-10. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00442286?
The interventions under investigation include: Rheos® Baroreflex Hypertension System (DEVICE).
Who is sponsoring clinical trial NCT00442286?
This trial is sponsored by CVRx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.